(0.31%) 5 115.89 points
(0.30%) 38 356 points
(0.35%) 15 984 points
(-0.99%) $83.02
(5.25%) $2.02
(0.30%) $2 354.30
(0.36%) $27.63
(4.11%) $960.00
(-0.28%) $0.932
(-0.47%) $10.97
(-0.59%) $0.796
(1.66%) $93.40
2 days till quarter result
(amc 2024-05-01)
Expected move: +/- 4.84%
@ $32.28
発行日: 15 2月 2024 @ 04:36
リターン: -26.23%
前回のシグナル: 2月 15 - 04:04
前回のシグナル:
リターン: 1.14 %
Live Chart Being Loaded With Signals
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally...
Stats | |
---|---|
本日の出来高 | 297 353 |
平均出来高 | 723 482 |
時価総額 | 1.15B |
EPS | $0 ( 2024-02-15 ) |
次の収益日 | ( $-0.210 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -36.08 |
ATR14 | $0.0230 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Noznesky Justin J | Sell | 1 500 | Common Stock |
2024-03-18 | Dahlquist Karl S. | Sell | 1 885 | Common Stock |
2024-03-14 | Carrel Michael H | Sell | 2 000 | Common Stock |
2024-03-12 | Noznesky Justin J | Sell | 1 500 | Common Stock |
2024-03-05 | Dahlquist Karl S. | Sell | 8 231 | Common Stock |
INSIDER POWER |
---|
47.74 |
Last 99 transactions |
Buy: 784 374 | Sell: 271 192 |
ボリューム 相関
AtriCure Inc 相関
10 最も負の相関 | |
---|---|
SIDU | -0.945 |
OBT | -0.929 |
QNST | -0.924 |
ATNX | -0.921 |
PEAR | -0.921 |
OPOF | -0.92 |
LSAK | -0.916 |
TRIT | -0.914 |
BON | -0.914 |
WNEB | -0.913 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
AtriCure Inc 相関 - 通貨/商品
AtriCure Inc 財務諸表
Annual | 2023 |
収益: | $399.25M |
総利益: | $297.42M (74.49 %) |
EPS: | $-0.660 |
FY | 2023 |
収益: | $399.25M |
総利益: | $297.42M (74.49 %) |
EPS: | $-0.660 |
FY | 2022 |
収益: | $330.38M |
総利益: | $245.94M (74.44 %) |
EPS: | $-1.020 |
FY | 2021 |
収益: | $274.33M |
総利益: | $205.86M (75.04 %) |
EPS: | $1.190 |
Financial Reports:
No articles found.
AtriCure Inc
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。